Published in Chemphyschem on December 07, 2009
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int (2008) 3.34
Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol (2008) 2.72
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol (2007) 2.62
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis (2008) 2.31
A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol (2003) 2.23
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation (2011) 1.87
Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis (2009) 1.79
Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis (2009) 1.74
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. Kidney Int (2009) 1.72
Pure red cell aplasia due to follow-on epoetin. Kidney Int (2008) 1.69
Fournier gangrene: role of imaging. Radiographics (2008) 1.68
Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Am J Kidney Dis (2009) 1.66
Alcohol and sexual risk behavior among migrant female sex workers and male workers in districts with high in-migration from four high HIV prevalence states in India. AIDS Behav (2010) 1.43
Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation. Kidney Int (2008) 1.43
Acute coronary syndrome in ESRD patients. Kidney Int (2008) 1.43
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis (2012) 1.38
Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect Immun (2007) 1.37
Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. Kidney Int (2008) 1.34
Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology (2013) 1.34
Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant (2009) 1.33
Disclosure of the HIV infection status in children. Indian J Pediatr (2009) 1.27
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J (2005) 1.25
Aerosol chemistry over a high altitude station at northeastern Himalayas, India. PLoS One (2010) 1.19
Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol (2009) 1.17
Con: Randomized controlled trials (RCT) have failed in the study of dialysis methods. Nephrol Dial Transplant (2013) 1.09
Polymer thin films embedded with metal nanoparticles for electrochemical biosensors applications. Biosens Bioelectron (2012) 1.06
Prevalence of vitamin D deficiency in Saudi adults. Saudi Med J (2013) 1.02
The role of systemic handling in the pathophysiologic actions of botulinum toxin. J Pharmacol Exp Ther (2008) 1.01
Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination. Infect Immun (2002) 1.00
Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study. Saudi J Kidney Dis Transpl (2010) 0.96
New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis (2004) 0.95
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis (2009) 0.95
Strategies for preservation of ovarian and testicular function after immunosuppression. Am J Kidney Dis (2004) 0.92
Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation (2006) 0.92
Role of vitamin D in chronic kidney disease. Semin Nephrol (2009) 0.90
Skull metastasis in papillary carcinoma of thyroid: A case report. World J Radiol (2012) 0.90
Outcome of acute kidney injury in pediatric patients admitted to the intensive care unit. Clin Nephrol (2014) 0.89
Chronic kidney disease in the Arab world: a call for action. Nephron Clin Pract (2012) 0.88
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease. Am J Nephrol (2013) 0.88
Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. Nephron Clin Pract (2008) 0.87
Tc-99m ciprofloxacin scans for detection of tubercular bone infection. Clin Nucl Med (2007) 0.87
Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure. Clin J Am Soc Nephrol (2006) 0.87
Heterocycle-based isomeric chromophores with substantially varying NLO properties: a new structure-property correlation study. J Phys Chem A (2008) 0.86
ESAs in dialysis patients: are you a hedgehog or a fox? J Am Soc Nephrol (2010) 0.86
Nephrobronchial fistula complicating neglected nephrolithiasis and xanthogranulomatous pyelonephritis. Saudi J Kidney Dis Transpl (2011) 0.85
De novo multifocal renal cell carcinoma in the renal allograft. Kidney Int (2008) 0.84
Transformation of tomato with a bacterial codA gene enhances tolerance to salt and water stresses. J Plant Physiol (2011) 0.83
Electron density and energy decomposition analysis in hydrogen-bonded complexes of azabenzenes with water, acetamide, and thioacetamide. J Phys Chem A (2005) 0.83
Posttransplant anemia: the role of sirolimus. Kidney Int (2009) 0.83
Significant increase in the stability of rare gas hydrides on insertion of beryllium atom. J Chem Phys (2007) 0.82
Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy. Nephron Clin Pract (2010) 0.82
Theoretical study of the effect of structural modifications on the hyperpolarizabilities of indigo derivatives. J Phys Chem A (2009) 0.82
Anemia in chronic kidney disease: new advances. Heart Fail Clin (2010) 0.82
The role of kidney biopsy in the management of lupus nephritis. Curr Opin Nephrol Hypertens (2005) 0.81
Immunopathogenesis of lupus and lupus nephritis: recent insights. Curr Opin Nephrol Hypertens (2002) 0.81
Photosensitization of nanoparticulate TiO2 using a Re(I)-polypyridyl complex: studies on interfacial electron transfer in the ultrafast time domain. Phys Chem Chem Phys (2012) 0.81
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. Am J Kidney Dis (2012) 0.81
Acute phosphate nephropathy. Kidney Int (2008) 0.81
The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol (2010) 0.80
Charge carrier dynamics in thiol capped CdTe quantum dots. Phys Chem Chem Phys (2010) 0.80
Polarizability, ionization potential, and softness of water and methanol clusters: an interrelation. J Phys Chem A (2012) 0.80
Anemia of chronic kidney disease. Clin J Am Soc Nephrol (2007) 0.79
Ultrafast dynamics of the excited states of 1-(p-nitrophenyl)-2-(hydroxymethyl)pyrrolidine. J Phys Chem A (2012) 0.79
Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. Semin Nephrol (2009) 0.79
Imaging of inflammatory bowel disease: CT and MR. Dig Dis (2004) 0.79
Comprehensive laboratory evaluation of a specific lateral flow assay for the presumptive identification of abrin in suspicious white powders and environmental samples. Biosecur Bioterror (2014) 0.79
Ultrafast dynamics of the excited states of curcumin in solution. J Phys Chem B (2010) 0.79
Deciphering the binding modes of hematoporphyrin to bovine serum albumin. Indian J Biochem Biophys (2014) 0.79
Static dipole polarizability and binding energy of sodium clusters Nan (n=1-10): A critical assessment of all-electron based post Hartree-Fock and density functional methods. J Chem Phys (2004) 0.79
Theoretical prediction of rare gas containing hydride cations: HRgBF+ (Rg = He, Ar, Kr, and Xe). J Phys Chem A (2013) 0.79
Ab initio studies of properties of small potassium clusters. J Phys Chem A (2008) 0.78
Strongly coupled ruthenium-polypyridyl complexes for efficient electron injection in dye-sensitized semiconductor nanoparticles. J Phys Chem B (2005) 0.78
A new method for radiolabeling of human immunoglobulin-G and its biological evaluation. J Pharm Bioallied Sci (2012) 0.78
Brain lesions with elevated lactic acid peaks on magnetic resonance spectroscopy. Curr Probl Diagn Radiol (2004) 0.78
The optimal hemoglobin in dialysis patients- a critical review. Semin Dial (2008) 0.78
Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease. Med Clin North Am (2005) 0.78
Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol (2008) 0.78
Multiple-timescale photoreactivity of a model compound related to the active site of [FeFe]-hydrogenase. Inorg Chem (2008) 0.78
Anaemia of CKD--the CHOIR study revisited. Nephrol Dial Transplant (2007) 0.78
An electrochemiluminescence assay for the detection of bio threat agents in selected food matrices and in the screening of Clostridium botulinum outbreak strains associated with type A botulism. J Sci Food Agric (2013) 0.78
Interfacial electron transfer between the photoexcited porphyrin molecule and TiO2 nanoparticles: effect of catecholate binding. J Phys Chem B (2006) 0.78
How ions affect the structure of water: a combined Raman spectroscopy and multivariate curve resolution study. J Phys Chem B (2013) 0.78
Hydrogen bonding in substituted formic acid dimers. J Phys Chem A (2006) 0.78
Ionized state of hydroperoxy radical-water hydrogen-bonded complex: (HO2-H2O)+. J Phys Chem A (2007) 0.77
Ultrafast intermolecular hydrogen bond dynamics in the excited state of fluorenone. J Phys Chem A (2005) 0.77
S2 fluorescence and ultrafast relaxation dynamics of the S2 and S1 states of a ketocyanine dye. J Phys Chem A (2005) 0.77
Dynamics of solvent controlled excited state intramolecular proton transfer coupled charge transfer reactions. Photochem Photobiol Sci (2013) 0.77
Probing excited state charge transfer dynamics in a heteroleptic ruthenium complex. Phys Chem Chem Phys (2014) 0.77
Hemoglobin target in chronic kidney disease: a pediatric perspective. Pediatr Nephrol (2008) 0.77
Excited state polarizabilities of methanol clusters. Phys Chem Chem Phys (2010) 0.77
Reducing versus discontinuing erythropoietin at high hemoglobin levels. J Am Soc Nephrol (2007) 0.77